Glycomics/Glycobiology Market by Product, Instruments, Kits & Reagents, Application & End User - Global Forecast to 2021 - Increasing Government and Private Funding for Glycomics & Proteomics Research - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Glycomics/Glycobiology Market by Product, Instruments, Kits & Reagents, Application, End User - Global Forecast to 2021" report to their offering.

The global glycomics market is poised to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3%. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the market. Whereas, the high degree of consolidation is expected to restrict the entry of new players in the market, and thereby hinder its growth.

On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment is projected to grow at the highest CAGR during the forecast period. This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures. The enzymes segment is further divided into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes.

On the basis of application, the market is segmented into diagnostics, drug discovery & development, oncology, immunology, and other applications. In 2016, the drug discovery and development segment is expected to account for the largest share of the market. This growth can be attributed to increase in R&D activities for the development of novel drugs and therapies.

On the basis of end user, the glycomics market is segmented into academic research institutes, pharmaceutical & biotechnology companies, and CROs. In 2016, the academic research institutes segment is projected to account for the largest share of the market. This growth can be attributed to the increasing government and private funding for proteomic and glycomics research.

Companies Mentioned:

  • Agilent Technologies, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • Merck KGaA
  • New England Biolabs Inc.
  • ProZyme, Inc.
  • Shimadzu Corporation
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Glycomics Market, By Product

7 Glycomics Market, By Application

8 Glycomics Market, By End User

9 Glycomics Market, By Region

10 Competitive Landscape

11 Company Profiles

12 Appendix

For more information about this report visit http://www.researchandmarkets.com/research/lln7qz/glycomicsglycobio

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology